Singapore conditionally clears laboratory deal

Singapore’s competition watchdog has accepted revised commitments offered by Pathology Asia to clear its purchase and merging of pathology companies Innovative Diagnostics and Quest Laboratories.


Get unlimited access to all Global Competition Review content